» Articles » PMID: 12721813

Idiopathic Parkinson's Disease: Possible Routes by Which Vulnerable Neuronal Types May Be Subject to Neuroinvasion by an Unknown Pathogen

Overview
Specialties Neurology
Physiology
Date 2003 May 2
PMID 12721813
Citations 668
Authors
Affiliations
Soon will be listed here.
Abstract

The progressive, neurodegenerative process underlying idiopathic Parkinson's disease is associated with the formation of proteinaceous inclusion bodies that involve a few susceptible neuronal types of the human nervous system. In the lower brain stem, the process begins in the dorsal motor nucleus of the vagus nerve and advances from there essentially upwards through susceptible regions of the medulla oblongata, pontine tegmentum, midbrain, and basal forebrain until it reaches the cerebral cortex. With time, multiple components of the autonomic, limbic, and motor systems become severely impaired. All of the vulnerable subcortical grays and cortical areas are closely interconnected. Incidental cases of idiopathic Parkinson's disease may show involvement of both the enteric nervous system and the dorsal motor nucleus of the vagus nerve. This observation, combined with the working hypothesis that the stereotypic topographic expansion pattern of the lesions may resemble that of a falling row of dominos, prompts the question whether the disorder might originate outside of the central nervous system, caused by a yet unidentified pathogen that is capable of passing the mucosal barrier of the gastrointestinal tract and, via postganglionic enteric neurons, entering the central nervous system along unmyelinated praeganglionic fibers generated from the visceromotor projection cells of the vagus nerve. By way of retrograde axonal and transneuronal transport, such a causative pathogen could reach selectively vulnerable subcortical nuclei and, unimpeded, gain access to the cerebral cortex. The here hypothesized mechanism offers one possible explanation for the sequential and apparently uninterrupted manner in which vulnerable brain regions, subcortical grays and cortical areas become involved in idiopathic Parkinson's disease.

Citing Articles

The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson's disease.

Cheng Y, Chiang H Neurol Sci. 2025; .

PMID: 40085320 DOI: 10.1007/s10072-025-08114-w.


The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration.

Ozturk M, Emgard J, Garcia-Revilla J, Fernandez-Calle R, Yang Y, Deierborg T Brain Commun. 2025; 7(2):fcaf087.

PMID: 40046336 PMC: 11879441. DOI: 10.1093/braincomms/fcaf087.


The Inflammatory Mechanism of Parkinson's Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut-Brain Axis.

Gao A, Lv J, Su Y Brain Sci. 2025; 15(2).

PMID: 40002492 PMC: 11853208. DOI: 10.3390/brainsci15020159.


Epigallocatechin-3-Gallate, Quercetin, and Kaempferol for Treatment of Parkinson's Disease Through Prevention of Gut Dysbiosis and Attenuation of Multiple Molecular Mechanisms of Pathogenesis.

Kalu A, Ray S Brain Sci. 2025; 15(2).

PMID: 40002477 PMC: 11853474. DOI: 10.3390/brainsci15020144.


Chronic DSS-Induced Colitis Exacerbates Parkinson's Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure.

Sharma N, Sharma M, Thakkar D, Kumar H, Smetanova S, Buresova L ACS Pharmacol Transl Sci. 2025; 8(2):346-367.

PMID: 39974653 PMC: 11833723. DOI: 10.1021/acsptsci.4c00286.